There are dozens of studies, innovations, and research findings released everyday by institutions and clinics across the world. Here’s a look at some of the other notable health reports from May 20-22.
Journal of Parkinson’s Disease Welcomes New Co-Editor-in-Chief Lorraine V. Kalia, MD, PhD, FRCPC
A globally recognized authority on Parkinson’s disease, Lorraine V. Kalia, MD, PhD, FRCPC, is an Associate Professor and Clinician Scientist in the Division of Neurology at the University of Toronto and a Senior Scientist at the Krembil Research Institute of the University Health Network.
Deciphering the biosynthetic gene cluster for potent freshwater toxin
Scientists from Scripps Institution of Oceanography at the University of California San Diego, the University of São Paulo and UC Santa Cruz collaborated to discover and validate the enzymes responsible for the production ofone of the most toxic and fast-acting neurotoxins associated with freshwater harmful algal blooms in lakes and ponds.
Resolution Time of COVID Vaccine-Related Lymphadenopathy
According to ARRS’ American Journal of Roentgenology (AJR), axillary lymphadenopathy detected by breast ultrasound after COVID-19 mRNA vaccination lasts longer than reported in initial vaccine clinical trials.
New Guidance Released for Preventing Hospital-Acquired Pneumonia
In the second in series of updates on guidance for infection control in acute-care hospitals, five medical organizations are recommending best practices for preventing hospital-associated pneumonia.
ZBP1 links interferon treatment and dangerous inflammatory cell death during COVID-19
Scientists from St. Jude Children’s Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell death pathway, PANoptosis, are major contributors to the negative effects of interferon treatment and high interferon levels in some COVID-19 patients.
Scientists smash lethal bacteria that acts like a hammer
New research from The Australian National University (ANU) could lead to better treatment options for a rare but very lethal type of bacterial infection.
New research shows no evidence of structural brain change with short-term mindfulness training
In new research, a team from the Center for Healthy Minds at the University of Wisconsin–Madison, led by Richard J. Davidson, found no evidence of structural brain changes with short-term mindfulness training.
Children who play adventurously have better mental health, research finds
Children who spend more time playing adventurously have lower symptoms of anxiety and depression, and were happier over the first Covid-19 lockdown, according to new research.
Research Sheds Light on Crimean-Congo Hemorrhagic Fever Disease Process
Army scientists determined that the body’s own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans.
Haywire T cells attack protein in “bad” cholesterol
LJI research reveals how aggressive T cells can make heart disease even worse.
PFAS chemicals do not last forever
Once dubbed “forever chemicals,” per-and polyfluoroalkyl substances, or PFAS, might be in the market for a new nickname.
A pioneering study discovers an underlying cause for infantile spasms and points to a novel therapy
A groundbreaking study, conducted in the laboratory of Dr. John Swann, director of the Gordon and Mary Cain Pediatric Neurology Research Foundation labs, investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital and professor at Baylor College of Medicine, has found that the levels of insulin growth factor -1 (IGF-1) and its downstream signaling are reduced in the brains of both IS patients and animal models.
UNC-Chapel Hill receives $65M from NIH for antiviral drug development center
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19.
Sleep Research Society announces 2022 award
The Sleep Research Society has selected three sleep and circadian scientists and a public health advocate as recipients of the 2022 SRS Awards, which recognize excellence in sleep and circadian research and advocacy.
Sleep societies announce 2022 Diversity, Equity, and Inclusion Leadership Award recipients
Sleep medicine professors and researchers Chandra Jackson and Girardin Jean-Louis are the recipients of the 2022 Diversity, Equity, and Inclusion Leadership Award from the Associated Professional Sleep Societies, LLC, a joint initiative of the American Academy of Sleep Medicine and the Sleep Research Society.
American Academy of Sleep Medicine announces 2022 award recipients
Four members of the American Academy of Sleep Medicine have been selected as the 2022 AASM award recipients for their contributions to the field of sleep medicine.
Scientists gain ground on rare congenital neurological disorder
Two recent discoveries co-led by scientists at Cedars-Sinai may help lead to new ways to treat patients with Allan-Herndon-Dudley syndrome (AHDS), a brain development disorder that causes severe intellectual disability and problems with movement.
DNA contained in honey reveals honeybee health
Researchers from the B.S.R.C. “Alexander Fleming” in Greece have optimized a method to characterize DNA traces in honey, revealing the species that honeybees interact with.
University of Limerick research reveals variety of opinions are crucial for ‘fostering trust’ in vaccination
Groundbreaking new University of Limerick research analysing global vaccine hesitancy has revealed that expressions of doubt are essential for promoting trust in vaccines.
Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders
James Bibb, Ph.D., and colleagues have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition.
Study identifies new molecular target for cancer therapy
Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have identified a new molecular drug target that could result in new cancer drugs with fewer side effects.
Risk Factors Identified for Autoimmune Hepatitis After Liver Transplant
A multicenter study performed by a large international consortium that includes UT Southwestern has outlined a set of risk factors and outcomes for patients with autoimmune hepatitis (AIH) that recurs after liver transplantation.
Killer T vs. memory – DNA isn’t destiny for T cells
Scientists from St. Jude Children’s Research Hospital uncovered how one type of T cell creates two genetically identical, but functionally different, daughter cells.
Study Finds Higher Excess Deaths During Omicron Period Compared to Delta Period in Massachusetts
A new study in JAMA compares excess deaths during the pandemic period when the Delta variant dominated (June 28, 2021-December 5, 2021), during the transition from Delta to the Omicron variant (December 6-26, 2021) and when Omicron dominated (December 27, 2021-February 20, 2022) in Massachusetts.